| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/06/2006 | EP1697419A2 Detection of cd20 in transplant rejection |
| 09/06/2006 | EP1697417A2 Antibodies against secretory leukocyte protease inhibitor |
| 09/06/2006 | EP1697415A1 NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO |
| 09/06/2006 | EP1697405A1 Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 09/06/2006 | EP1697403A2 Haemophilus influenzae type iv pili |
| 09/06/2006 | EP1697396A2 Mrna transfected antigen presenting cells |
| 09/06/2006 | EP1697033A1 Cryogranulation and storage method for active pharmaceutical agents |
| 09/06/2006 | EP1696964A1 Use of microparticles for antigen delivery |
| 09/06/2006 | EP1696956A2 Anti-cd52 antibody treatment for diabetes |
| 09/06/2006 | EP1696955A2 Detection of cd20 in therapy of autoimmune diseases |
| 09/06/2006 | EP1696954A1 Vaccine composition admixed with an alkylphosphatidylcholine |
| 09/06/2006 | EP1696953A1 Recombinant vibrio cholerae strain and vaccine comprising said strain |
| 09/06/2006 | EP1696952A1 Anti-retroviral agents, compositions, methods and uses |
| 09/06/2006 | EP1696951A1 Immunotherapy for food allergy by reduced and alkylated food allergens |
| 09/06/2006 | EP1696950A2 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its use for the treatment of angiogenic-related disorders |
| 09/06/2006 | EP1696949A2 Vegf receptor antagonists |
| 09/06/2006 | EP1696942A1 Pharmaceutical product comprising tissue of the male vegetal reproductive system |
| 09/06/2006 | EP1696895A1 Modulation of 5-ht2 receptors as a treatment for cardiovascular diseases |
| 09/06/2006 | EP1696886A1 Drug delivery compositions and methods |
| 09/06/2006 | EP1322383B9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 09/06/2006 | EP1282642B1 Therapeutic pore-forming peptides |
| 09/06/2006 | EP1088075B1 Aav structural protein, production and use thereof |
| 09/06/2006 | EP1071449B1 Use of an antagonist antibody to the inflammatory mediator oncostatin m (osm) |
| 09/06/2006 | EP1023435B1 Novel lactic acid bacteria species |
| 09/06/2006 | EP0955366B1 Antigenic protein originating in malassezia |
| 09/06/2006 | EP0815204B1 Method for treating tumors by alloactivated human donor lymphocytes |
| 09/06/2006 | EP0789762B1 Methods for the diagnosis of glaucoma |
| 09/06/2006 | EP0760857B9 Receptor for oncostatin m |
| 09/06/2006 | CN1829917A Evaluation of adjuvanted vaccines |
| 09/06/2006 | CN1829799A Recombinant influenza vectors with a POLII promoter and ribozymes |
| 09/06/2006 | CN1829796A Novel full-length genomic rna of Japanese encephalitis virus, infectious jev cDNA therefrom, and use thereof |
| 09/06/2006 | CN1829741A Treatment with anti-VEGF antibodies |
| 09/06/2006 | CN1829740A Connective tissue growth factor antibodies |
| 09/06/2006 | CN1829533A Antibodies and fusion proteins that include engineered constant regions |
| 09/06/2006 | CN1829532A Use of myostatin (GDF8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders |
| 09/06/2006 | CN1829531A Method of inhibiting tumor growth with anti-tissue factor antibodies |
| 09/06/2006 | CN1829530A Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds |
| 09/06/2006 | CN1829529A Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof |
| 09/06/2006 | CN1829526A Soluble CLCA-1 and antagonists to CLCA-1 |
| 09/06/2006 | CN1829524A Anti-HIV-1 compounds based upon a conserved amino acid sequence shared by GP160 and the human CD4 protein |
| 09/06/2006 | CN1827777A Application of osteopontin inhibitor in rheumatoid arthritis treatment |
| 09/06/2006 | CN1827646A Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/06/2006 | CN1827636A Protective polypeptide of human influenza A virus, its use, vaccine and diagnostic tool |
| 09/06/2006 | CN1827172A Pig viral infectious disease gene recombined live vaccine using canine II type adenovirus as carrier and preparation process thereof |
| 09/06/2006 | CN1827168A Treatment of t cell mediated autoimmune disorders |
| 09/06/2006 | CN1273593C Gene cloning of polyepitope antigen of hepatitis C virus and its coding sequence |
| 09/06/2006 | CN1273489C Monoclone antibody against HnRNP A2/B1 antigen, its preparation and use |
| 09/06/2006 | CN1273488C Gene reform immune globulin with low immunogenicity and its application |
| 09/06/2006 | CN1273482C Hepatitis C virus tunic protein E2 gene capable of being total length expressed in E. coli, its coding protein and use |
| 09/06/2006 | CN1273196C Target directional confluent DNA vaccine for preventing caries and preparation method thereof |
| 09/06/2006 | CN1273193C Method for preparing biologics of yolk antibody for resisting Helicobacter Pylori |
| 09/06/2006 | CN1273192C Method and composition for altering a T cell mediated pathology |
| 09/06/2006 | CN1273191C Method and composition for altering a B cell mediated pathology |
| 09/06/2006 | CN1273190C 疫苗组合物 Vaccine composition |
| 09/06/2006 | CN1273189C West nile vaccine |
| 09/06/2006 | CN1273188C Method for culturing Calmette-Guerin bacillus or inactivated Calmette-Guerin bacillus |
| 09/05/2006 | US7101990 Bax-responsive genes for drug target identification in yeast and fungi |
| 09/05/2006 | US7101989 Isolated polynucleotides of DNA, a polynucleotide that hybridizes to the DNA, or a polynucleotide that encodes a full length DsrA. |
| 09/05/2006 | US7101979 Antibodies to antiangiogenic compositions and methods |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101973 β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 09/05/2006 | US7101963 Chlamydia pneumoniae polypeptides and uses thereof |
| 09/05/2006 | US7101962 Antibodies of the P2Y10 receptor useful in altering T lymphocyte function |
| 09/05/2006 | US7101850 WISP polypeptides and nucleic acids encoding same |
| 09/05/2006 | US7101705 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 09/05/2006 | US7101695 Preparing protein cross-linking enzymes for use in food processing and drug delivevry |
| 09/05/2006 | US7101685 Recombinant Sendai virus |
| 09/05/2006 | US7101562 Conjugate vaccines for the prevention of dental caries |
| 09/05/2006 | US7101561 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 09/05/2006 | US7101560 Combination vaccine for administration to adolescents |
| 09/05/2006 | US7101559 Immunomodulatory protein and useful embodiments thereof |
| 09/05/2006 | US7101558 bvg-positive Bordetella bronchiseptica strain; grows at a higher rate, more reliably in a less expensive medium; purity |
| 09/05/2006 | US7101557 Promoting coagulation in prothrombotic blood vessels, treating a vascularized tumor with a coagulation-deficient tissue factor compound |
| 09/05/2006 | US7101556 Preparation and usage of plasmodium fusion antigen |
| 09/05/2006 | US7101555 Microorganismal polypeptides for use in diagnosis and treatment of respiratory system disorders; genetic vaccines |
| 09/05/2006 | US7101554 Picornaviruses, vaccines and diagnostic kits |
| 09/05/2006 | US7101553 Administering prebiotic such as fructo-oligosaccharide; measles prevention; vaccines; nutrients |
| 09/05/2006 | US7101552 Preferential particle for inducing immume respone to viral disease and lymphadenopathy associated viruses |
| 09/05/2006 | US7101551 Substance which inhibits binding between E2/NS1 protein of hepatitis C virus and cell infectious with hepatitis C virus, a cell expressing CD81, or CD81 |
| 09/05/2006 | US7101550 Agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response |
| 09/05/2006 | US7101549 nucleic acid molecules and polypeptide molecules that encode glycoprotein VI; modulating agents in regulating a variety of cellular processes |
| 09/05/2006 | US7101548 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 09/05/2006 | US7101547 administering anti-substance P antibody fragments to treat viral or bacterial-induced inflammation of the lung |
| 09/05/2006 | US7101543 Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells |
| 09/05/2006 | US7101539 Increasing hematopoietic progenitor cells in a mammal by adminstering an interleukin-like polypeptide |
| 09/05/2006 | CA2178504C Immunoassays for prostate specific antigen |
| 09/05/2006 | CA2143642C Immunoreactive peptides from epstein-barr virus |
| 09/05/2006 | CA2099707C Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins |
| 09/03/2006 | WO2006096164A1 Media for clostridium bacterium and processes for obtaining a clostridial toxin |
| 09/03/2006 | WO2006096163A1 Animal product free system and process for purifying a botulinum toxin |
| 09/03/2006 | CA2556796A1 Animal product free system and process for purifying a botulinum toxin |
| 09/03/2006 | CA2556537A1 Media for clostridium bacterium and processes for obtaining a clostridial toxin |
| 08/31/2006 | WO2006091798A2 Vaccines and methods for prevention and treatment of drug-resistant hiv-1 and hepatitis b virus |
| 08/31/2006 | WO2006091796A2 Compositions and methods for diagnosing and treating retinal diseases |
| 08/31/2006 | WO2006091733A2 Method for enhancing the immune response to staphylococcus aureus infection |
| 08/31/2006 | WO2006091722A2 Alkyl-glycoside enhanced vaccination |
| 08/31/2006 | WO2006091721A2 Porcine helicobacter infection |
| 08/31/2006 | WO2006091693A2 Extending time to disease progression or survival in cancer patients using a her dimerization inhibitor |
| 08/31/2006 | WO2006091587A2 Use of minoxidil sulfate as an anti-tumor drug |
| 08/31/2006 | WO2006091381A1 Humanized anti-ghrelin antibodies |